4//SEC Filing
Biohaven Pharmaceutical Holding Co Ltd. 4
Accession 0001562180-22-007082
CIK 0001935979operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 5:40 PM ET
Size
7.5 KB
Accession
0001562180-22-007082
Insider Transaction Report
Form 4
Biohaven Ltd.BHVN
Transactions
- Other
Common Shares
2022-10-03+35,839,857→ 35,839,857 total - Other
Common Shares
2022-10-03−35,839,857→ 0 total
Footnotes (2)
- [F1]On October 3, 2022, in connection with the distribution by Biohaven Pharmaceutical Holding Company Ltd. ("RemainCo") of the outstanding common shares of the Issuer ("Common Shares") pursuant to the Separation and Distribution Agreement, dated May 9, 2022, between RemainCo and the Issuer, the Issuer issued to RemainCo 35,839,857 Common Shares (the "Issuance").
- [F2]On October 3, 2022, immediately following the Issuance, all of the outstanding common shares of the Issuer held by RemainCo were distributed by way of a pro rata distribution to RemainCo's shareholders (the "Distribution"). As a result of the Distribution, RemainCo no longer beneficially owns any common shares of the Issuer and consequently is no longer subject to the requirements of Section 16 of the Exchange Act with respect to the Issuer.
Documents
Issuer
Biohaven Ltd.
CIK 0001935979
Entity typeoperating
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001689813
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 5:40 PM ET
- Size
- 7.5 KB